Daehan New Pharm to supply 60 billion won protein A

Daehan New Pharm said Monday that has established a a marketing and distribution partnership with the U.S. based GenScript and Japan based Pharmawin to supply protein A worth 60 billion won.

The capacity of protein A to bind antibodies with such high affinity is the driving motivation for its industrial scale use in biologic pharmaceuticals. The protein A used for production of antibodies in...